Title : POTENTIAL ADVANTAGE OF REPAGLINIDE MONOTHERAPY IN GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES AND SEVERE RENAL IMPAIRMENT.

Pub. Date : 2017 Apr-Jun

PMID : 31149163






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Focusing on 4 patients who received DPP-4 inhibitor monotherapy at enrolment, switching to repaglinide also significantly improved HbA1c levels. repaglinide dipeptidyl peptidase 4 Homo sapiens
2 In case that DPP-4 inhibitors are not enough to achieve targeted range of glycemic control, repaglinide is another good candidate. repaglinide dipeptidyl peptidase 4 Homo sapiens